Results 191 to 200 of about 1,859,513 (388)
In vivo mutations in human blood cells: biomarkers for molecular epidemiology.
, 1993 Richard J. Albertini +5 more
openalex +1 more source
Use and misuse of biomarker tests in “environmental conditions” [PDF]
, 1994 John E. Salvaggio
openalex +1 more source
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews. Cancer, 2019 J. Havel, D. Chowell, T. Chan
semanticscholar +1 more source
Molecular Oncology, EarlyView.Combining melting curve analysis enhances the multiplexing capability of digital PCR. Here, we developed a 14‐plex assay to simultaneously measure single nucleotide mutations and amplifications of KRAS and GNAS, which are common driver genes in pancreatic cancer precursors. This assay accurately quantified variant allele frequencies in clinical samples
Junko Tanaka +10 more
wiley +1 more source
DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality [PDF]
, 1994 openalex +1 more source
Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma
Molecular Oncology, EarlyView.This study leveraged public datasets and integrative bioinformatic analysis to dissect malignant cell heterogeneity between relapsed and primary HCC, focusing on intercellular communication, differentiation status, metabolic activity, and transcriptomic profiles.
Wen‐Jing Wu +15 more
wiley +1 more source
Biomarkers in epidemiology: scientific issues and ethical implications.
, 1992 Paul A. Schulte
openalex +1 more source
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. [PDF]
, 1995 Goberdhan P. Dimri +9 more
openalex +1 more source